news: BEVERLY, MA—Dec 16, 2013 – Cellceutix
news:
BEVERLY, MA—Dec 16, 2013 – Cellceutix Corporation (OTCQB: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to announce that it has submitted the application to the Institutional Review Board (“IRB”) responsible for the Company’s planned Phase 2b clinical trial of its novel antibiotic Brilacidin as a drug candidate for Acute Bacterial Skin and Skin Structure Infections (“ABSSSI”).
The protocol for the clinical trial was constructed following the successful completion of a Phase 2a clinical trial of Brilacidin for ABSSSI. The Company anticipates that the trials will commence on schedule in just a few weeks, in January 2014. The clinical trial information will soon be updated on www.clinicaltrials.gov
Cellceutix is particularly excited about the timing of its recent acquisition of novel antibiotic and antifungal compounds because of the introduction last week of the ADAPT (Antibiotic Development to Advance Patient Treatment) Act of 2013 by the House of Representatives to expedite development of new antibiotics and antifungal drug candidates. The bill builds upon the GAIN (Generating Antibiotic Incentives Now) Act that was passed in 2012 to provide incentives, such as extended periods of exclusivity and smaller patient populations for clinical trials, for new antibiotics that target areas of great unmet medical need. The FDA is demonstrating its commitment to find solutions to the growing problem of bacteria infections. Cellceutix feels its drug candidates are prime candidates to benefit from these government initiatives.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...
Continue Reading
Investment Gold in Abilene's Storage Sector Diving headfirst into the world of bricks and mortar, the opportunity brewing over in Abilene, Texas, packs a potent punch for anyone keen on beefing up their real estate portfolio with a top-notch asset. We're talking about Spare Feet Self Storage, a slick, Class A self-storage facility, serving the cream of the crop in a...
Continue Reading
A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...
Continue Reading
Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...
Continue Reading
Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...
Continue Reading
An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....
Continue Reading
In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...
Continue Reading
Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...
Continue Reading
An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....
Continue Reading
Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...
Continue Reading
Top 5 Most Recently Viewed Articles
Decoding the Door Weather Strip Market Dynamics The Door Weather Strip Market is currently undergoing a transformative phase, fueled by a rising global demand for better energy efficiency in buildings and vehicles. These essential sealing materials play a pivotal role in enhancing comfort by blocking draughts, water, dust, and noise, thereby creating more pleasant...
Continue Reading
So, 60 Degrees Pharmaceuticals decided to roll out this pilot program for ARAKODA® back in 2024, right? And let me tell ya, it wasn't just any old initiative; they were all about ramping up awareness and getting people on this antimalarial train. Traders took notice immediately—ARAKODA® was the only new antimalarial drug approved in over a decade, which should've...
Continue Reading
Constellation Software Financial Highlights Constellation Software Inc. (TSX: CSU) recently reported its financial outcomes for the second quarter, showcasing encouraging revenue growth accompanied by a quarterly dividend announcement. The company has declared a dividend of $1.00 per share, payable to eligible shareholders later in the year. Growth in Revenue During the...
Continue Reading
Golar LNG's Major Financing Achievement Golar LNG Limited is thrilled to announce the successful closure and drawdown of a substantial $1.2 billion asset-backed debt facility. This agreement, reached with a consortium of reputable banks, marks a significant milestone for the company's ongoing projects involving the FLNG Gimi. The banking consortium includes prominent...
Continue Reading
The Rise of the Duty Free and Travel Retail Market In recent years, the Duty Free and Travel Retail market has become a captivating area of focus, showcasing incredible growth. A recent report reveals that this sector, which was valued at approximately USD 38.9 billion in 2023, is on a trajectory to reach around USD 77.8 billion by 2033. This remarkable growth is...
Continue Reading